Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy
about
Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitisInvolvement of Kallikrein-Related Peptidases in Normal and Pathologic ProcessesTissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold - A Potential Therapeutic Intervention for Skin DiseasesKallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.Inhibition of transcription factor specificity protein 1 alters the gene expression profile of keratinocytes leading to upregulation of kallikrein-related peptidases and thymic stromal lymphopoietin.Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment.Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis.A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology.Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Stratum corneum proteases and dry skin conditions.Proteases and proteomics: cutting to the core of human skin pathologies.Predictions for the future of kallikrein-related peptidases in molecular diagnostics.Unleashing the therapeutic potential of human kallikrein-related serine proteases.Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil.Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids.Expression of serine protease inhibitors in epidermal keratinocytes is increased by calcium but not 1,25-dihydroxyvitamin D3 or retinoic acid.Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
P2860
Q24632061-F251A15C-A3A4-4FDD-89A2-BAEC38EB9C7EQ26771266-DD6DCC2B-BDFD-4515-8DB6-09172DB2865FQ28553241-44201DB0-E479-41F8-9161-B8F2373AF02EQ33715944-68AD3AA3-FC5C-4AFF-BD62-B337AD6BC73AQ35349913-064AEAF7-1E10-430C-B7AF-84CF71CCDBCDQ35350228-B4759F5A-E8AA-41BC-881F-7EB1C3BB00CBQ35916032-D409380B-7D78-41A1-BD44-A4BFE043E205Q37216587-3A751519-59F2-44BC-A241-9B38908D966CQ37697808-382BBEE5-4076-478A-B4BB-FCBD746F5890Q37952006-594C2F8C-4110-47A0-B5DD-D8D8751749A5Q38050991-1F0A201E-4116-4A6D-9463-3C76237DD442Q38200069-67BD969C-1E04-4D99-96CE-FC8064148323Q38220044-4AD79FB9-FA79-49AB-AC22-516B07374681Q38362486-36FF9D97-B885-4826-9622-75E3429CA9E5Q38760061-188A2D2C-201D-44FB-B6E6-F3638121F1DFQ38922640-CC91AC9F-8588-49B3-801E-E8CBD5814C09Q41854925-97A702EC-F452-4174-A30E-658DE9009FE4Q51353874-A562A5A4-7994-464F-BBD6-B49A660882F8Q51626598-E9DFE9BB-B1DE-46B8-9FFD-0874C97EA37C
P2860
Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy
description
im Mai 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2007
@uk
name
Aberrant human tissue kallikre ...... henotype, severity and therapy
@en
Aberrant human tissue kallikre ...... henotype, severity and therapy
@nl
type
label
Aberrant human tissue kallikre ...... henotype, severity and therapy
@en
Aberrant human tissue kallikre ...... henotype, severity and therapy
@nl
prefLabel
Aberrant human tissue kallikre ...... henotype, severity and therapy
@en
Aberrant human tissue kallikre ...... henotype, severity and therapy
@nl
P2093
P2860
P1476
Aberrant human tissue kallikre ...... henotype, severity and therapy
@en
P2093
P2860
P304
P356
10.1111/J.1365-2133.2006.07743.X
P407
P577
2007-05-01T00:00:00Z